These results support [18F] JNJ-64326067 as a novel isoquinoline PET tracer for the detection and quantitation of tau aggregates in Alzheimer’s disease research, joining the armamentarium of imaging biomarkers for detection of tau pathology. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.